STOCK TITAN

Eli Lilly (LLY) Form 144 Notice — 2,000 RSU Shares to Be Sold

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice for Eli Lilly & Co. (LLY) reports a proposed sale of 2,000 common shares through Morgan Stanley Smith Barney LLC on 08/28/2025 on the NYSE with an aggregate market value of $1,468,340.00. The shares were acquired as Restricted Stock Units on 02/09/2022 from the issuer and payment information is listed as N/A.

The filer reports no securities sold during the past three months. The form includes the standard representation that the selling person is not aware of undisclosed material adverse information and provides space for signature and plan-adoption dates, but those fields are not populated in the supplied content.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine insider sale notice for 2,000 RSU-derived shares valued at $1.47M; no recent sales reported.

The filing documents a proposed sale under Rule 144 of 2,000 common shares acquired as restricted stock units on 02/09/2022. The sale is scheduled through Morgan Stanley Smith Barney LLC on 08/28/2025 at the NYSE and shows an aggregate market value of $1,468,340.00. The disclosure that no shares were sold in the prior three months limits concerns about recent disposition activity. The form does not include the seller's identity, plan-adoption date, or signature in the provided text.

TL;DR: Compliance-focused filing; it contains required representations but lacks populated signature or plan-adoption details in the excerpt.

The submission appears to fulfill Rule 144 procedural disclosure by identifying the broker, class, quantity, acquisition type, and planned sale date. It reiterates the seller's representation regarding material nonpublic information and references Rule 10b5-1 planning, but the provided content does not show a signed attestation or a 10b5-1 adoption date. Those missing elements are notable for completeness but are not unusual in partial extracts.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filed for LLY report?

It reports a proposed sale of 2,000 common shares acquired as Restricted Stock Units on 02/09/2022, to be sold on 08/28/2025 with aggregate market value $1,468,340.00.

Through which broker will the LLY shares be sold?

The filing lists Morgan Stanley Smith Barney LLC as the broker, with an indicated NY address and execution on the NYSE.

Were any LLY securities sold by the person in the past three months?

The Form 144 states "Nothing to Report" for securities sold during the past three months.

How were the shares being sold acquired?

The shares were acquired as Restricted Stock Units from the issuer on 02/09/2022.

Does the filing show a signed attestation or 10b5-1 plan date?

In the provided content, signature and plan-adoption/instruction date fields are not populated.